American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Anti-aging Treatments, Skin Lighteners Tied to Mercury Poisoning

Skin Products Not Manufactured in U.S. Come Under FDA Scrutiny

By Lisa Curran

The FDA reports that recent mercury poisoning cases have been linked to certain skin creams, soaps and lotions, particularly products marketed as skin lighteners and anti-aging treatments.
Stillman's Skin Bleach Cream
The mercury-containing products, which were not manufactured in the United States, have been found in at least seven states. The FDA typically does not allow mercury in drugs or cosmetics.

The agency advises that consumers discontinue use of products that contain "mercurous chloride," "calomel," "mercuric," "mercurio" or "mercury." If ingredients are not listed on a product, the product should not be used, say FDA officials.

According to Scott Plensdorf, M.D., of Flint, Mich., patients at risk for using these products are usually teens and women. He recommends that physicians talk with their patients about "the need to be informed consumers with all skin care products to prevent potential serious health consequences to both them and their families."

Symptoms of mercury poisoning can include numbness or pain in certain areas of the skin and uncontrollable shaking or tremors, says the NIH.

Plensdorf says that for creams to be effective, they likely will have to be used for several months, leading to repeated exposures. And mercury poisoning is not the only possible effect of using untested products.

"Since the active ingredients haven't even been tested to determine their concentration, I worry that significant adverse effects, such as dermatitis and burning of the skin and mucous membranes, may occur," he notes.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

DTaP Remains in Short Supply This Summer

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control